With even the Supreme Court weighing in on generic vs brand-name drugs, Dr. Roger Steinert offers his opinion on this ongoing debate and what it means for practicing ophthalmologists.
Dr. Monte Mills takes a quick tour of the most interesting topics from this year's American Association for Pediatric Ophthalmology and Strabismus (AAPOS) meeting in San Antonio.
Considerable interest surrounds microincision glaucoma surgery (MIGS), with its less invasive approach. Dr. Roger Steinert explores the surgical techniques and comments on their impact on practice.
At what point should you consult with an ophthalmologist when a patient has candidemia? Paul G. Auwaerter, MD, describes a recent study that sheds light on this topic.
Dr. John Marshall says that his efficiency as a clinician is undermined as he spends more and more time entering data into the EMR with less and less administrative support. Is there a way out?
The rising prevalence of diabetes will contribute to huge numbers of patients with diabetic retinopathy. Find out how best to preserve vision in these patients.
ICD-10 will have a huge impact on physicians' daily lives and revenue. It's important to make the transition smooth and be ready, or the practice could end up losing significant money when billing.
CMS Administrator Donald M. Berwick, MD, MPP, and Richard J. Gilfillan, MD, Acting Director, Center for Medicare and Medicaid Innovation, discuss the final ACO rules and how they will affect doctors.
Dr. Roger Steinert offers his insights on the recent European Society of Cataract & Refractive Surgeons meeting. What are the anticipated latest advances and developments?